Coumarins scaffolds as COX inhibitors

Area of Science:

• Biochemistry
• Pharmacology
• Natural Products Chemistry

Background:

• Cyclooxygenase (COX) enzymes are key mediators of inflammation, pain, cancer, and neuropsychiatric disorders.
• Non-steroidal anti-inflammatory drugs (NSAIDs) targeting COX-2 have limitations, including severe cardiac side effects.
• Coumarins (benzopyrans) are natural and synthetic compounds with diverse biological activities, including anti-inflammatory properties.

Purpose of the Study:

• To review the potential of natural and synthetic coumarins as inhibitors of COX enzymes.
• To explore the therapeutic applications of coumarins in inflammation and related conditions.
• To highlight the current stage of research and future development scope for coumarin-based COX inhibitors.

Main Methods:

• Literature review of studies on coumarins and their interaction with COX enzymes.
• Analysis of existing data on the anti-inflammatory activities of natural and synthetic coumarins.
• Examination of the structural features of coumarins relevant to COX inhibition.

Main Results:

• Coumarins exhibit significant anti-inflammatory activity, acting as potential COX inhibitors.
• Both natural and synthetic coumarins have demonstrated efficacy in preclinical studies.
• The study identifies coumarins as a promising class of compounds for developing novel anti-inflammatory agents.

Conclusions:

• Coumarins represent a valuable scaffold for the development of new COX inhibitors.
• Despite early-stage research, coumarins offer a promising alternative to existing NSAIDs.
• Further investigation into coumarin derivatives could lead to safer and more effective anti-inflammatory therapies.